ABMD Financial Facts
Net loss: 2.68MProvision for income taxes: 559K
See Full Income Statement
Additional paid-in-capital: 401.77M
Cash and cash equivalents: 5.99M
See Full Balance Sheet
Earnings History for Abiomed Inc. (ABMD)
|
Expand Research on ABMD
| Next EPS Date | 8/2/13 *Est. | EPS Growth Rate | -30.8% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +111.3% | Revenue Growth Rate | +17.2% *Last Qtr. |
| Average % Move 1-Wk after EPS | -8.7% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/13  |
 |
Q413 | $0.09 | $0.07 | +$0.02 | $43.7M | $41.95M | N/A / N/A | = | +16.7% | Details |
| 2/6/13 |
|
Q313 | $0.07 | $0.07 | $0.00 | $38.3M | $38.04M | N/A / N/A | N/A | +51.5% | Details |
| 11/1/12 |
|
Q213 | $0.20 | $0.05 | +$0.15 | $37.4M | $37.47M | N/A / N/A | N/A | +10.1% | Details |
| 5/16/12 |
Q412 | $0.13 | $0.06 | +$0.07 | $37.3M | $34.98M | N/A / N/A | N/A | -8% | Details | |
| 2/3/12 |
|
Q312 | $0.11 | -$0.01 | +$0.12 | $32.2M | $31.43M | N/A / N/A |  |
+13.5% | Details |
| 11/3/11 |
|
Q212 | $0.09 | -$0.09 | +$0.18 | $29.5M | $27.7M | N/A / N/A | |
+50.4% | Details |
| 8/2/12 |
|
Q112 | $0.16 | $0.03 | +$0.13 | $38.8M | $36.88M | N/A / N/A | |
-5% | Details |
| 8/4/11 |
|
Q112 | -$0.03 | -$0.06 | +$0.03 | $27.4M | $27.79M | N/A / N/A | |
+43.2% | Details |
